Analyzing Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and Longevity Health (NASDAQ:XAGE)

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and Longevity Health (NASDAQ:XAGE) are both small-cap manufacturing companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Inspira Technologies OXY B.H.N. and Longevity Health, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1	0	0	0	1.00
Longevity Health	0	0	0	0	0.00

Profitability

This table compares Inspira Technologies OXY B.H.N. and Longevity Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
Longevity Health	-682.67%	N/A	-261.90%

Valuation & Earnings

This table compares Inspira Technologies OXY B.H.N. and Longevity Health”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$289,000.00	179.12	-$13.22 million	N/A	N/A
Longevity Health	$1.05 million	0.44	-$10.37 million	($4.29)	-0.06

Longevity Health has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Risk and Volatility

Inspira Technologies OXY B.H.N. has a beta of 4.06, meaning that its share price is 306% more volatile than the S&P 500. Comparatively, Longevity Health has a beta of 0.38, meaning that its share price is 62% less volatile than the S&P 500.

Insider and Institutional Ownership

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 24.2% of Longevity Health shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Comparatively, 29.0% of Longevity Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Inspira Technologies OXY B.H.N. beats Longevity Health on 6 of the 9 factors compared between the two stocks.

About Inspira Technologies OXY B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra’annana, Israel.

About Longevity Health

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.